VOLITIONRX LTD 4
4 · VOLITIONRX LTD · Filed Sep 15, 2015
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Colman Alan
Director
Transactions
- Disposition to Issuer
Option (Right to Buy)
2015-05-18−5,000→ 0 totalExercise: $3.00From: 2012-05-25Exp: 2015-05-25→ Common Stock (5,000 underlying) - Disposition to Issuer
Option (Right to Buy)
2015-05-18−5,000→ 0 totalExercise: $5.00From: 2014-11-25Exp: 2017-11-25→ Common Stock (5,000 underlying) - Award
Option (Right to Buy)
2015-05-18+5,000→ 5,000 totalExercise: $4.00From: 2013-11-25Exp: 2017-11-25→ Common Stock (5,000 underlying) - Award
Option (Right to Buy)
2015-05-18+5,000→ 5,000 totalExercise: $3.00From: 2012-05-25Exp: 2016-05-25→ Common Stock (5,000 underlying) - Award
Option (Right to Buy)
2015-05-18+5,000→ 5,000 totalExercise: $4.00From: 2013-05-25Exp: 2017-05-25→ Common Stock (5,000 underlying) - Award
Option (Right to Buy)
2015-05-18+5,000→ 5,000 totalExercise: $5.00From: 2014-05-25Exp: 2018-05-25→ Common Stock (5,000 underlying) - Disposition to Issuer
Option (Right to Buy)
2015-05-18−5,000→ 0 totalExercise: $4.00From: 2013-05-25Exp: 2016-05-25→ Common Stock (5,000 underlying) - Disposition to Issuer
Option (Right to Buy)
2015-05-18−5,000→ 0 totalExercise: $5.00From: 2014-05-25Exp: 2017-05-25→ Common Stock (5,000 underlying) - Award
Option (Right to Buy)
2015-05-18+5,000→ 5,000 totalExercise: $3.00From: 2012-11-25Exp: 2016-11-25→ Common Stock (5,000 underlying) - Award
Option (Right to Buy)
2015-05-18+5,000→ 5,000 totalExercise: $5.00From: 2014-11-25Exp: 2018-11-25→ Common Stock (5,000 underlying) - Disposition to Issuer
Option (Right to Buy)
2015-05-18−5,000→ 0 totalExercise: $3.00From: 2012-11-25Exp: 2015-11-25→ Common Stock (5,000 underlying) - Disposition to Issuer
Option (Right to Buy)
2015-05-18−5,000→ 0 totalExercise: $4.00From: 2013-11-25Exp: 2016-11-25→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on November 25, 2011 and fully-vested on November 25, 2014, and were exercisable for three years from the date first exercisable. The "replacement" options are fully-vested and exercisable for a period of four years from the date first exercisable.